Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase

Current Report No. 4/2024

Date of preparation: January 19, 2024

Subject: Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase.

Legal basis: Article 56 (1) (2) of the Act on Public Offering - current and periodic information

The Management of Captor Therapeutics S.A., based in Wrocław, Poland (the "Company") announces that on 19 January 2024, the Company's Management Board adopted a resolution on the issue of 17,134 series R ordinary bearer shares, within the limits of the Company's authorized capital, excluding, in full, the pre-emptive rights of the Company's existing shareholders.

The share issue is related to the implementation of a share-based incentive programme for employees and members of the Company's bodies. The Company discloses the content of the adopted resolution.